Description: AegirBio AB (publ), a diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and Asia. The company focuses on the neurology, cancer, and autoimmune diseases therapeutic areas. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. AegirBio AB (publ) was incorporated in 2019 and is headquartered in Lund, Sweden.
Home Page: aegirbio.com
Scheelevägen 27
Lund,
223 63
Sweden
Phone:
46 4 62 86 54 00
Officers
| Name | Title |
|---|---|
| Dr. Bradley Messmer Ph.D. | CEO, Chief Scientific Officer & Member of the Board |
| Patrik Gotthardt | Interim Chief Financial Officer |
| Mr. Jens Patrik Elfwing | COO & Director |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2946 |
| Price-to-Sales TTM: | 31.8028 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 17 |